Table 4.
The biomarker of lung cancer changed with CT examination.
| Pre-Period of CT | Peri-Period of CT | Period of CT | p | |
|---|---|---|---|---|
| TP53 | 0.001 | |||
| Mutant type | 102 (54.8) | 22 (50.0) | 94 (39.5) | |
| Wild type | 84 (45.2) | 22 (50.0) | 144 (60.5) | |
| PD-L1 in tumor cells | 0.240 | |||
| <1% | 96 (52.5) | 27 (62.8) | 141 (59.7) | |
| ≥1% | 87 (47.5) | 16 (37.2) | 95 (40.3) | |
| PD-L1 in immune cells | 0.081 | |||
| <1% | 41 (24.3) | 11 (26.2) | 32 (13.6) | |
| <5% | 44 (26.0) | 6 (14.3) | 74 (31.5) | |
| <10% | 44 (26.0) | 13 (31.0) | 64 (27.2) | |
| ≥10% | 40 (23.7) | 12 (28.6) | 65 (27.7) | |
| Ki-67, median (IQR) | 35 (60) | 20 (50) | 15 (35) | <0.001 |